Abstract 2192: Safety and Efficacy Is Sustained Up To One Year after Transplantation of Autologous CD34+ Cells in No-Option Patients with Chronic Critical Limb Ischemia
Circulation(2006)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined